Deeper Knowledge, Faster

  • Plan your formulary budget
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Federal Trade Commission
Cantor Fitzgerald
Farmers Insurance

Generated: July 21, 2017

DrugPatentWatch Database Preview

ECOZA Drug Profile

« Back to Dashboard

What is the patent landscape for Ecoza, and when can generic versions of Ecoza launch?

Ecoza is a drug marketed by Chemo Research Sl and is included in one NDA. There is one patent protecting this drug.

This drug has eighteen patent family members in fifteen countries.

The generic ingredient in ECOZA is econazole nitrate. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the econazole nitrate profile page.

Summary for Tradename: ECOZA

Suppliers / Packagers: see list1
Bulk Api Vendors: see list104
Patent Applications: see list680
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ECOZA at DailyMed

Pharmacology for Tradename: ECOZA

Drug ClassAzole Antifungal
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chemo Research Sl
econazole nitrate
AEROSOL, FOAM;TOPICAL205175-001Oct 24, 2013RXYesYes5,993,830► SubscribeY ► Subscribe
Chemo Research Sl
econazole nitrate
AEROSOL, FOAM;TOPICAL205175-001Oct 24, 2013RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: ECOZA

Country Document Number Estimated Expiration
Brazil9806774► Subscribe
Australia5786198► Subscribe
Spain2234091► Subscribe
JapanH10226637► Subscribe
Norway313314► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:

Google Plus